AlphaCore Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Buy |
22,495
+3,459
| +18% | +$160K | 0.04% | 252 |
|
|
2025
Q1 | $1.16M | Buy |
19,036
+354
| +2% | +$21.6K | 0.1% | 155 |
|
|
2024
Q4 | $1.06M | Sell |
18,682
-575
| -3% | -$32.5K | 0.23% | 72 |
|
|
2024
Q3 | $996K | Sell |
19,257
-2,919
| -13% | -$151K | 0.22% | 75 |
|
|
2024
Q2 | $921K | Sell |
22,176
-2,036
| -8% | -$84.6K | 0.22% | 72 |
|
|
2024
Q1 | $1.31M | Buy |
24,212
+1,964
| +9% | +$107K | 0.35% | 53 |
|
|
2023
Q4 | $1.14M | Sell |
22,248
-5,257
| -19% | -$270K | 0.17% | 92 |
|
|
2023
Q3 | $1.6M | Sell |
27,505
-14,025
| -34% | -$814K | 0.25% | 68 |
|
|
2023
Q2 | $2.66M | Buy |
41,530
+27,955
| +206% | +$1.79M | 0.43% | 50 |
|
|
2023
Q1 | $941K | Buy |
13,575
+103
| +0.8% | +$7.14K | 0.25% | 56 |
|
|
2022
Q4 | $969K | Buy |
13,472
+1,446
| +12% | +$104K | 0.38% | 31 |
|
|
2022
Q3 | $855K | Buy |
12,026
+3,392
| +39% | +$241K | 0.39% | 27 |
|
|
2022
Q2 | $665K | Buy |
8,634
+3,124
| +57% | +$241K | 0.31% | 35 |
|
|
2022
Q1 | $402K | Buy |
+5,510
| New | +$402K | 0.16% | 50 |
|
|
2020
Q2 | – | Sell |
-888
| Closed | -$49K | – | 99 |
|
|
2020
Q1 | $49K | Buy |
+888
| New | +$49K | 0.04% | 105 |
|